Type 2 Diabetes Flashcards

1
Q

Classification of Type 2 diabtes

A

insulin resistance with relative insulin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classes of Drugs used in Type 2 diabtets

A

Insulin Secretagogues
Insulin Sensitizers
a-Glucosidase Inhibitor
Dipeptidyl Peptidase IV Inhibitors: DPP-IV
Glucagon-like Peptide-1 GLP-1 Mimetic
Sodium-glucose co-transporter 2 SGLT2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Function of Insulin Secretagogues

A

Increase basal and/or postprandial insulin levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The action of Insulin Secretagogues depend on

A

Functional B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which are the Insulin Secretagogues

A

Sulfonylureas
Meglitinides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dosing of the Sulfonylureas

A

1-2 times daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dosing of Meglitinides

A

3-4 times daily

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AEs of Insulin Secretagogues

A

Weight gain
Hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Insulin Secretagogues cause a reduction in

A

Microalbuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which are the 2nd gen Sulfonylureases

A

Gibenclamide
Gliclazide
Glipazide
Glimepiride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which are the long acting Sulfonylureas

A

Gibenclamide
Glimepiride
DOA: 24 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which are the short acting Sulfonylureas

A

Glipizide
Gliclazide
DOA: 12-24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MOA of Sulfonylureas

A

Incr. Insulin secretions
Decr. Hepatic clearance of insulin
decr. Glucagon levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CIs of Sulfonylureas

A

Significant Hepatic/renal impairment–> incr. T1/2 of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AEs of Sulfonylureas

A

Hypoglycemia
NV
Headache
Allergic skin rxn
Minor Disulfiram-like rxns
Cardiotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DIs with Sulfonylureas

A

Aspirin + Sulphonamides: potentiate effecrs of Sulfonylureas
-Hepatic enzyme inducers
-Corticosteroids
-Oral contraceptives
–> decr. effects of Sulfonylureas
B-Blockers mask signs of hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which are the Meglitinides?

A

Repaglinide
Nateglanide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

MOA of Meglitinides

A

Bind to ATP dependent K channels causing insulin release
*have no effect on lipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Can Meglitinides be used with the Sulfonyureases

A

Nope, they Incr. insulin secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Repaglinide can be combined with

A

Metformin
Thiazolidine-diones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AEs of Repaglinide

A

Hypoglycemia
URTIs
Weight gain
Bronchitis
Headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MOA of Nateglinide

A

Rapid onset action: 3x more than Repa..
–> incr. early phase of insulin release
Rapid-off action: 5x more than Repa
–> insulin return to pre-prandial levels 3-4 hrs
–> decr. risk of postprandial hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

AEs of Nateglinide

A

Nausea
diarrhea
Mild Hypoglycemia
*no increase in body weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are Thiazolidinediones

A

They are insulin sensitisers= enhance effects of insulin
-decr. glucose ouptout in liver
-incr. glucose uptake and incr. insulin sensitivity in mucsles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
MOA of Thiazolidinediones
Are agonists at Peroxisome Proliferator-activated receptor-γ (PPARγ) --> induce insulin genes
26
The induction of insulin genes cause
incr. expression of glucose transporter Rs --> decr. glucose output by incr. glucose uptake by incr. glucose sensitivity in muscles
27
Why is the therapeutic effect of Thiazolidinediones delayed
Bcos they work at the gene transcription levels --> induce insulin genes and decr. peripheral resistance of insulin *ddelayed for 4-12 wks
28
Name a Thiazolidinedione
Pioglitazone
29
Effects of Pioglitazone
Decr. Trigs and FFA levels Incr. HDL levels No effect on LDL levels Decr. rsk of Hypoglycemia
30
Therapeutic uses of Pioglitazone
Monotherapy
31
Pioglitazone can be used in combination with
Sulfonylureases Metformin Injected insulin
32
AEs of Pioglitazone
Fluid retention--> Oedema Weight gain Anemia CVD Incr. riks of Cardiac ischaemia
33
What is Metformin
Its a insulin sensitiser
34
MOA of Metformin
Incr. insulin sensitivity decr. hepatic glucose production, fasting insulin Decr. Trigs, FFA, LDL leves Incr. HDL levels Decr. risk for developmeny of macrovascular complications
35
Name a Metformin agent
Biguanides
36
Where does Metformin act
Liver: decr. glucose output Muscle: incr. glucose uptake
37
Uses of Biguanide (metformin)
1st line drug in Type 2 diabetes
38
Biguanide can be used in combination with
Sulfonylureases Meglitinide Thiazolidinediones Insulin or a-glucosidase inhibitor
39
AEs of Biguanide
GI disturbances such as: -abdominal discomfort -diarrhea -Metallic taste -mild anorexia Lactic Acidosis
40
CIs of Biguanide
Renal impairment Hepatic disease Alcohol use Predisposition to CV, collapse, acute CHF, sever infection History of Lactic Acidosis
41
Name an a-glucosidase inhibitor
Acarbose
42
MOA of Acarbose
inhibits the breakdowm of CHO comples in SI--> delays CHO absorption inhibits glucoamylase>sucrase>maltase>dextranase
43
Benefits of taing Acarbose
decr. postprandial hyperglycemia no effect on lipids or insulin levels
44
AEs of Acarbose
GI disturbances Dose-dependent toxicity
45
CIs of Acarbose
Inflammatory bowel disease GI obstruction Cirrhosis
46
Acarbose can combined with
Insulin Metformin SUlfonylureases --> has an additive effect
47
What are incretins
Are a group of GI enzymes that cause an icrease in the amount of insulin released from B-cells --> Enhance GLP-1 activity= insulin enhanced
48
Function of Dipeptidyl Peptidase IV
Breakdown/inactivates GLP-1
49
What are DPP4 Inhibitors
They are incretin enhancers thus they inhibit the DPP-IV enzyme
50
Effect of DPP4 inhibitors
they extend the action of insulin while suppressing release of glucagon
51
Which are the DPP4 inhibitors
Sitagliptin Vildagliptin Saxagliptin
52
DPP4 inhibitors can be combined with
Insulin Metformin Slufonylureases --> have an additive effect
53
AEs of DPP4 inhibitors
GIT discomfort Peripheral oedema Liver dysfunction
54
Cautions when using DPP4 inhibitors
Renal impairment
55
Which are the GLP-1 mimetics
LEDS Liraglutide Exenatide Dulaglutide Semaglutide
56
MOA of GLP-1 mimetics
are incretin mimietics exhibit GLP-1 actions incr. insulin secretion decr. glucagon secretion
57
Admin of GLP-1 mimetics
SC L: 1x daily E: 2x daily s: 1x daily
58
Effects of GLP-1 mimetics
May promote weight loss CVS benefits
59
AEs of GLP-1 mimetics
Hypoglycemia NV Rash Pancreatitis
60
CIs in GLP-1 mimetics
Type 1 diabetics (as functional B-cells are required and they dont have these) Ketoacidosis Severe renal Impairment PREGNANCY
61
Function of Sodium-glucose co-transporter 2 SGL2 inhibitors
they prevent kidneys from reabsorbing glucose back into blood --> kidneys can remove excess glucose
62
Which are the SGL2 inhibitors
CDE Canagliflozin Dapagliflozin Empagliflozin
63
MOA of SGL2 inhibitors
are competitive selective inhibitors of SGL2 thus prevent the kidneys from reabsorbing glucose into blood
64
SGL2 inhibitors can be used with
Metformin Pioglitazone Sitagliptin
65
Admin SGL2 inhibitors
orally once a day before 1st meal
66
CIs with SGL2 inhibitors
Renal impairment PREGNANCY LACTATION
67
AEs of SGL2 inhibitors
Incr. risk of gental_urinary tract infections Hypotension